Top of the morning to you, and a fine one it is. A shiny sun and crisp breeze are enveloping the Pharmalot campus, where the short people have left for the local schoolhouse and gainful employment, respectively, leaving us with the official mascot to sort out the morning routine. And of course, this means we are, once again, firing up the coffee kettle for a cup of stimulation. And why not? The neurons can use a little help. Feel free to join us if you agree. Meanwhile, time to get cracking. Here are some items of interest. Hope you have a splendid day and, as always, do keep in touch. …

The Food and Drug Administration plans to provide “concierge service” to doctors seeking access to unapproved drugs for cancer patients who have no other treatment options, The Washington Post writes. The pilot will include Project Facilitate, a new call center run by the agency’s oncology staff to provide a single point of contact for doctors submitting requests for the program. Although the agency has streamlined its expanded-access program in recent years, the process still may seem confusing to doctors who have little experience with it.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy